Haoqi Pan

618 total citations · 1 hit paper
21 papers, 430 citations indexed

About

Haoqi Pan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haoqi Pan has authored 21 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haoqi Pan's work include Pancreatic and Hepatic Oncology Research (5 papers), Peptidase Inhibition and Analysis (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Haoqi Pan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Peptidase Inhibition and Analysis (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Haoqi Pan collaborates with scholars based in China and Canada. Haoqi Pan's co-authors include C. Shen, Jiayu Fu, Xiao‐Ming Li, Si Shi, Xiaodan Yu, Yi Zhu, Ying Zhang, Qixin Sun, Di Zheng and Xianjun Yu and has published in prestigious journals such as Nature Medicine, Gut and Chemical Engineering Journal.

In The Last Decade

Haoqi Pan

21 papers receiving 428 citations

Hit Papers

Histone lactylation: from tumor lactate metabolism to epi... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haoqi Pan China 11 147 104 57 55 46 21 430
Lingyu Kong China 13 290 2.0× 102 1.0× 26 0.5× 68 1.2× 30 0.7× 39 729
Dayu Sun China 15 259 1.8× 113 1.1× 33 0.6× 19 0.3× 34 0.7× 29 616
Mengzhen Wang China 13 159 1.1× 64 0.6× 50 0.9× 33 0.6× 25 0.5× 44 474
Daniele de Paula Faria Brazil 16 145 1.0× 54 0.5× 51 0.9× 38 0.7× 35 0.8× 68 638
Hyojung Lee South Korea 10 327 2.2× 69 0.7× 34 0.6× 75 1.4× 24 0.5× 15 559
Hadi Aligholi Iran 16 244 1.7× 167 1.6× 45 0.8× 37 0.7× 29 0.6× 75 766
Paula C. Reggiani Argentina 13 159 1.1× 108 1.0× 19 0.3× 20 0.4× 26 0.6× 38 580
Hongqiang Yin China 12 142 1.0× 62 0.6× 21 0.4× 64 1.2× 21 0.5× 20 372
Chunmei Liang China 13 238 1.6× 65 0.6× 67 1.2× 100 1.8× 11 0.2× 30 497

Countries citing papers authored by Haoqi Pan

Since Specialization
Citations

This map shows the geographic impact of Haoqi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoqi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoqi Pan more than expected).

Fields of papers citing papers by Haoqi Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoqi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoqi Pan. The network helps show where Haoqi Pan may publish in the future.

Co-authorship network of co-authors of Haoqi Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Haoqi Pan. A scholar is included among the top collaborators of Haoqi Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoqi Pan. Haoqi Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pan, Haoqi, Jing Yang, Mingming Xiao, et al.. (2024). MXene-based dual-gated multifunctional nanodrug induced ferroptosis and modulated tumor microenvironment to treat pancreatic cancer. Chemical Engineering Journal. 500. 157233–157233. 3 indexed citations
3.
Lei, Yalan, Jin Xu, Mingming Xiao, et al.. (2024). Pirfenidone alleviates fibrosis by acting on tumour–stroma interplay in pancreatic cancer. British Journal of Cancer. 130(9). 1505–1516. 6 indexed citations
4.
Pan, Haoqi, Zhouyu Ning, Litao Xu, et al.. (2024). Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial. Signal Transduction and Targeted Therapy. 9(1). 347–347. 3 indexed citations
5.
Xiao, Mingming, H. J. Yang, Xiaoqi Mao, et al.. (2024). NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy. Cell Death and Disease. 15(8). 620–620. 5 indexed citations
6.
Pan, Haoqi, et al.. (2024). Histone lactylation: from tumor lactate metabolism to epigenetic regulation. International Journal of Biological Sciences. 20(5). 1833–1854. 61 indexed citations breakdown →
7.
Xiao, Mingming, Rong Tang, Haoqi Pan, et al.. (2024). TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality. Gut. 74(3). 410–423. 3 indexed citations
8.
Pan, Haoqi, Mingming Xiao, Xu He, et al.. (2024). Multifunctional RGD coated a single-atom iron nanozyme: A highly selective approach to inducing ferroptosis and enhancing immunotherapy for pancreatic cancer. Nano Research. 17(6). 5469–5478. 5 indexed citations
9.
Kang, Xiaohong, Xiaomei Liu, Haifeng Wang, et al.. (2023). Nomogram for predicting the preoperative lymph node metastasis in resectable pancreatic cancer. Journal of Cancer Research and Clinical Oncology. 149(13). 12469–12477. 3 indexed citations
11.
Zhang, Yiyin, Haoqi Pan, Wenchao Chen, et al.. (2022). Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress. Frontiers in Endocrinology. 13. 865655–865655. 19 indexed citations
12.
Li, Tianpeng, Tingting Shen, Jing Sun, et al.. (2022). Using One-Step Acid Leaching for the Recovering of Coal Gasification Fine Slag as Functional Adsorbents: Preparation and Performance. International Journal of Environmental Research and Public Health. 19(19). 12851–12851. 10 indexed citations
13.
Xia, Shunjie, Lin Ji, Liye Tao, et al.. (2021). TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance. Cellular and Molecular Gastroenterology and Hepatology. 12(3). 1121–1143. 19 indexed citations
14.
Mao, Qijiang, Haoqi Pan, Boqiang Liu, et al.. (2021). Whole-exon sequencing insights into pancreatic synovial sarcoma: a case report. Gland Surgery. 10(5). 1812–1818. 1 indexed citations
15.
Liu, Jingyi, Xinjie Zhang, Qiang Zheng, et al.. (2021). A dual-layer cell-laden tubular scaffold for bile duct regeneration. Materials & Design. 212. 110229–110229. 11 indexed citations
16.
Cen, Dong, Zhe Wan, Yike Fu, et al.. (2020). Implantable fibrous ‘patch’ enabling preclinical chemo-photothermal tumor therapy. Colloids and Surfaces B Biointerfaces. 192. 111005–111005. 13 indexed citations
17.
Pan, Haoqi, et al.. (2020). HGF/c-Met Axis: The Advanced Development in Digestive System Cancer. Frontiers in Cell and Developmental Biology. 8. 801–801. 13 indexed citations
18.
Zhang, Ying, Yi Zhu, Shu-Xia Cao, et al.. (2020). MeCP2 in cholinergic interneurons of nucleus accumbens regulates fear learning. eLife. 9. 16 indexed citations
19.
Shen, C., Di Zheng, Kexin Li, et al.. (2019). Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior. Nature Medicine. 25(2). 337–349. 165 indexed citations
20.
Zhang, Yaqian, Haoqi Pan, & Zhang Feng-e. (2019). Solvothermal synthesis of CDs/Bi4O5Br2 nanocomposites with improved visible-light photocatalytic ciprofloxacin (CIP) decontamination. Materials Letters. 251. 114–117. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026